News

Chungnam National University Researchers Develop A Rapid Water Quality Monitoring Chip for Antibiotic Detection

DAEJEON, South Korea, Dec. 20, 2024 /PRNewswire/ -- Antimicrobial resistance (AMR) is a growing global health crisis because of microbes,…

1 year ago

Pickleball Kingdom and PodPlay to Enter Exclusive Relationship

Pickleball Kingdom Signs Multi-Year Agreement Bringing PodPlay's Industry-Leading Technology to nearly 400 Pickleball Kingdom Franchises  PHOENIX, Dec. 20, 2024 /PRNewswire/…

1 year ago

UF/IFAS, Florida Strawberry Industry, and Ohalo Join Forces to Combat Devastating Fungal Disease

APTOS, Calif., Dec. 20, 2024 /PRNewswire/ -- Ohalo Genetics, Inc. has entered into a groundbreaking Development & Commercialization Agreement with…

1 year ago

Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference

WARSAW, Ind., Dec. 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the…

1 year ago

Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), is pleased…

1 year ago

American Health Imaging Brings State-of-Art Medical Imaging to the Greater Huntsville Area

Two New Outpatient MRI & CT Centers are Now Open in Huntsville and Madison, Alabama HUNTSVILLE, ALABAMA / ACCESSWIRE /…

1 year ago

Top Healthcare IT Vendors Driving Interoperability and Transforming Care Delivery in Brazil, India, Singapore, South Africa, and Italy: Black Book Research

TAMPA, FLORIDA / ACCESSWIRE / December 20, 2024 / Black Book Research, a leading healthcare IT market research firm, has…

1 year ago

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

WILMETTE, Ill., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar” or the “Company”), a clinical-stage biotechnology…

1 year ago

Channel Therapeutics Highlights Differences Between NaV1.7 and NaV1.8 in Light of Recent Clinical Data on Suzetrigine 

FREEHOLD, N.J., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer…

1 year ago

BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points

SAN DIEGO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company (“BioAtla” or the…

1 year ago